“The @WhiteHouse is encouraged by the bipartisan work of Chairman Grassley and Senator Wyden to craft a comprehensive package to lower outrageously high drug prices, and today we are engaging with coalitions to help build support…” –White House Deputy Press Secretary Judd Deere
“AARP thanks Chairman Chuck Grassley and Ranking Member Ron Wyden for their bipartisan work to address high drug prices. We commend the Senate Finance Committee for including an out-of-pocket cap on prescription drugs for seniors in Medicare Part D and for proposing to crack down on drugmakers that raise prices higher than the rate of inflation…”
AARP represents and advocates on behalf of nearly 38 million older Americans
“We applaud the Committee for coming together in a bipartisan way… Giving Big Pharma meaningful liability and accountability for their high drug prices is essential for keeping premiums low for seniors and reducing costs for taxpayers.”
America’s Health Insurance Plans (AHIP) represents members who provide health care and prescription coverage across the country
“The bipartisan proposal from Senate Finance takes meaningful steps to increase access and reduce the cost of prescription drugs for America's patients.”
The Association for Accessible Medicine (AAM) represents America’s manufacturers and distributors of generics and biosimilar drugs.
“We applaud Chairman Grassley and Ranking Member Wyden for their dedication to lowering prescription drug prices for Americans… and look forward to working with committee members to advance measures to hold Big Pharma accountable.”
The Campaign for Sustainable Rx Pricing (CSRxP) is a coalition of physicians, nurses, hospitals, consumers, health plans, PBMs, pharmacists, and businesses.
“Americans are demanding action to lower drug prices, and the Senate Finance Committee has taken an important step forward with its proposals today… The package protects innovation and maintains patient access to innovative drugs.”
Patients for Affordable Drugs now is run by a blood cancer patients, a breast cancer survivor along with former Democratic and Republican communicators.
“Senate health care leaders have developed a bipartisan, fiscally responsible way to reduce the cost of the Medicare prescription drug benefit, also known as Medicare Part D.”
Avik Roy, noted conservative economist, is president of the Foundation for Research on Equal Opportunity